✦ LIBER ✦

PCN39 COST UTILITY OF HUMAN PAPILOMA VIRUS VACCINE IN SPAIN

✍ Scribed by D Callejo; A Lopez-Polin; JA Blasco

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN33 COST UTILITY ANALYSIS OF VACCINATI

✍ GM Ginsberg; M Fisher; I Ben-Shahar; J Bornstein 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

PCN72 Cost - Effectiveness Analysis of C

✍ García-Jurado, L.; Morano, R.; Torné, A.; Malvar, A.; Bayas, J.M.; Casado, M.A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN35 COST-EFFECTIVENESS OF HUMAN PAPILL

✍ F de La Hoz; N Alvis; J Narváez; O Gamboa; A Chocontá 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Cost-effectiveness of human papillomavir

✍ Mireia Diaz; Silvia de Sanjose; Jesse Ortendahl; Meredith O’Shea; Sue J. Goldie; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 398 KB

Cost-effectiveness of human papilloma vi

✍ KRISTJAN ODDSSON; JAKOB JOHANNSSON; TINNA LAUFEY ASGEIRSDOTTIR; THOROLFUR GUDNAS 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 73 KB

Budget impact and cost-utility analysis

✍ Imaz, Iñaki; Rubio, Beltrán; Cornejo, Ana M.; González-Enríquez, Jesús 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 413 KB